About IVCC
READ TIME
IVCC is the only Product Development Partnership (PDP) working in vector control. IVCC was established in 2005, through an initial $50million grant to the Liverpool School of Tropical Medicine (LSTM) from the Bill & Melinda Gates Foundation, and is a registered charity in the UK. We work with stakeholders to facilitate the development of novel and improved public health insecticides and formulations to combat the rapidly growing problem of insecticide resistance. We bring together partners from industry, the public sector and academia to create new solutions to prevent disease transmission. By focusing resources and targeting practical scientific solutions we accelerate the process from innovation to impact.
Vision
Saving lives, protecting health and increasing prosperity by preventing insect-borne diseases.
Mission
Building partnerships that create innovative solutions to prevent the transmission of insect-borne disease.
Purpose
IVCC works with stakeholders to facilitate the development of novel and improved public health insecticides and formulations, and provides information tools to enable their effective use. Although primarily focused on malaria, IVCC recognises that new tools and products are likely to be effective against a wide range of other vector-borne diseases.
IVCC Guiding Principles
- Vector control is fundamental to the elimination and eradication of insect-borne disease.
- Insect vector resistance to insecticides remains a constant challenge that must be overcome.
- A sense of urgency and focus on the delivery of accessible and affordable tools to populations most affected by insect-borne disease.
- An ability to work collaboratively with a diverse group of stakeholders to deliver on the IVCC mission and build an integrated approach to eradicate malaria and other Neglected Tropical Diseases (NTDs).
- Transparency, open communication and trust with all partners.
Strategy
Whilst our primary focus is and will continue to be the elimination and eradication of malaria, we recognise that our work has the potential and opportunity to reach much further; to support the control, elimination and eradication of other mosquito-borne NTDs beyond sub-Saharan Africa.
Originally funded through a $50 million grant from the Bill & Melinda Gates Foundation, IVCC is now supported by six further funding partners including UKAID, USAID, Unitaid, the Swiss Agency for Development and Cooperation (SDC), the Global Fund and Australian Aid. The solutions IVCC develop are principally concerned with the development of new public health insecticides for use on Insecticidal Treated Nets (ITNs) and Indoor Residual Spraying (IRS) which primarily come in the form of repurposed insecticides from agriculture or animal health and the development of novel Active Ingredients (AI).
IVCC continues to actively explore new and alternative vector control solutions that can complement the core products , recognising that a broad spectrum of vector control tools will give IVCC the greatest chance of fulfilling its mission and goals.
IVCC’s strategy continues to flex and adapt to meet the changing environment. In recent years increasing attention has turned to how IVCC can best support the delivery and optimised access and use of the innovative vector control solutions within endemic countries. This evolution of the strategy is currently represented through two major catalytic projects; NgenIRS and the New Nets Project.
IVCC is a dynamic organisation that has proven itself capable of proactively responding to the evolving malaria and NTD environment. IVCC will continue to evolve and innovate around its core mission to ensure that it is best positioned to save lives through vector control.
Successes
Insecticide resistance threatens to undermine successes in the fight against insect-borne diseases, like malaria. That’s why at IVCC we help create innovative solutions for vector control.
We have made great strides towards achieving this mission and have recorded many key accomplishments to date. These include the evaluation of over 4.5 million compounds for potential use as public health insecticides, leading to six classes of novel AIs identified for possible development and the development of a diagnostic system for malarial insecticide resistance detection. Recently, we supported the launch of two new long lasting IRS formulations, Sumitomo’s SumiShield® 50WG and Bayer’s Fludora® Fusion. They expand the range of vector control tools for challenging malarial insecticide resistance, we also launched insecticide quantification kits to monitor spray programme implementation.
IVCC have facilitated the first two African vector control field trial sites to achieve Good Laboratory Practice (GLP) certification and continue to support other sites with this aim. Through our Market Access work, and projects such as NGenIRS and the New Nets Project, we are working with partners to establish sustainable, competitive and growing markets for vector control tools, making them more accessible and affordable for millions of people.
Our Team
The IVCC core team is small and effective. We work best in partnership with many other skilled experts in academia, industry, funders, and malaria control programmes worldwide. Our team represents a breadth of experience and expertise, spanning many sectors and countries.
Justin McBeath
Chief Executive Officer
Danielle Brennan
Project Manager
Lynn Byrne
Office Manager and Secretary to Board of Trustees
Dr Marlize Coleman
Project Manager
Andrew Deyi Saibu
Africa Regional Coordinator
Helen Fletcher
Project and Business Administrator
Dr Christen Fornadel
Senior Technical Coordinator
Dr Stephania Herodotou
Materials Scientist
Terri-Lee Holmes
Legal Officer
John Hughes
Finance Project Officer
Karen Johnson
Senior Project and Business Administrator
Chris Larkin
Director - Communications and Operations
Dr Laura Roberts
Communications Manager
David McGuire
Director - Access and Market Shaping
Dr Tom McLean
Senior Advisor, Access and Strategy
Sara McManus
Project and Business Administrator
Mathias Mondy
Director - Strategy, Portfolio and Project Management
Natalie Lissenden
Technical Manager
Dr Derric Nimmo
Director - Technical Development
Larry Norton
Senior Project Manager
Duncan Preston
Director - Finance
Dr Jason Richardson
Technical Manager
Dr Svetlana Ryazanskaya
Technical Manager
Dr Graham Small
Senior Technical Manager
L Smedley
Portfolio Finance Manager
Janneke Snetselaar
Technical Manager
Ioana Ursu
Global Market Insight and Access Manager
Gary Ward
Project and Business Administrator
David Worrall
Group Legal and Intellectual Property Adviser
Fred Yeomans
Senior Project Manager
Dr Alan Ayers
Consultant and Senior Technical Advisor
Jameel Bharmal
Trials Support Consultant – East Africa
Dr Julian Entwistle
Consultant
Dr Angela Harris
Consultant
Dr Michael MacDonald
Consultant
Dr Welbeck Oumbouke
Trials Support Consultant - West Africa
Vasanthan Paul John
Consultant and ESAC Member
Governance
IVCC is a not-for-profit company registered as a charity in the UK. The strategy and scope of IVCC is directed by its core team under governance of the Board of Trustees, who represent a wide range of expertise.
Advisory Committees
Our external advisory advice committees and groups provide expert specialist advice, guidance as well as advice and assessment of vector control products in development. Each advisory group have specific terms of reference underpinned by the members’ expert scientific knowledge.
Funding Partners
We are grateful for the commitment of all our funders, which enables us to move forward to the final stages of developing the much-needed new public health insecticides that will transform vector control in the coming decades.
Industry Partners
At IVCC we work with world leading agricultural companies to create innovative solutions to combat the problem of insecticide resistance. The high level of commitment and support that IVCC has received from its industry partners means that we are saving lives today. Without their hard work and dedication, our Research and Development work would not be where it is today. Through ZERO by 40, these partners have reaffirmed their commitment to support the research, development and supply of innovative vector control solutions to help eradicate malaria by 2040.
